209 related articles for article (PubMed ID: 19787278)
1. G2-checkpoint abrogation in irradiated lymphocytes: A new cytogenetic approach to assess individual radiosensitivity and predisposition to cancer.
Terzoudi GI; Hatzi VI; Barszczewska K; Manola KN; Stavropoulou C; Angelakis P; Pantelias GE
Int J Oncol; 2009 Nov; 35(5):1223-30. PubMed ID: 19787278
[TBL] [Abstract][Full Text] [Related]
2. A standardized G2-assay for the prediction of individual radiosensitivity.
Pantelias GE; Terzoudi GI
Radiother Oncol; 2011 Oct; 101(1):28-34. PubMed ID: 22014898
[TBL] [Abstract][Full Text] [Related]
3. Increased G2 chromosomal radiosensitivity in cancer patients: the role of cdk1/cyclin-B activity level in the mechanisms involved.
Terzoudi GI; Jung T; Hain J; Vrouvas J; Margaritis K; Donta-Bakoyianni C; Makropoulos V; Angelakis P; Pantelias GE
Int J Radiat Biol; 2000 May; 76(5):607-15. PubMed ID: 10866282
[TBL] [Abstract][Full Text] [Related]
4. G2 checkpoint control and G2 chromosomal radiosensitivity in cancer survivors and their families.
Cadwell KK; Curwen GB; Tawn EJ; Winther JF; Boice JD
Mutagenesis; 2011 Mar; 26(2):291-4. PubMed ID: 21044988
[TBL] [Abstract][Full Text] [Related]
5. G2/M Checkpoint Abrogation With Selective Inhibitors Results in Increased Chromatid Breaks and Radiosensitization of 82-6 hTERT and RPE Human Cells.
Nikolakopoulou A; Soni A; Habibi M; Karaiskos P; Pantelias G; Terzoudi GI; Iliakis G
Front Public Health; 2021; 9():675095. PubMed ID: 34123995
[TBL] [Abstract][Full Text] [Related]
6. The benzene metabolite hydroquinone enhances G2-chromosomal radiosensitivity by inducing a less-efficient G2-M-checkpoint in irradiated lymphocytes.
Hatzi VI; Terzoudi GI; Pantelias GE; Spiliopoulou C; Makropoulos V
Int J Oncol; 2007 Jul; 31(1):145-52. PubMed ID: 17549415
[TBL] [Abstract][Full Text] [Related]
7. Checkpoint abrogation in G2 compromises repair of chromosomal breaks in ataxia telangiectasia cells.
Terzoudi GI; Manola KN; Pantelias GE; Iliakis G
Cancer Res; 2005 Dec; 65(24):11292-6. PubMed ID: 16357135
[TBL] [Abstract][Full Text] [Related]
8. Genetic determination of chromosomal radiosensitivities in G0- and G2-phase human lymphocytes.
Borgmann K; Haeberle D; Doerk T; Busjahn A; Stephan G; Dikomey E
Radiother Oncol; 2007 May; 83(2):196-202. PubMed ID: 17499867
[TBL] [Abstract][Full Text] [Related]
9. Chromosomal radiosensitivity in Ukrainian breast cancer patients and healthy individuals.
Ryabchenko NM; Glavin OA; Shtefura VV; Anikushko MF
Exp Oncol; 2012 Jul; 34(2):121-4. PubMed ID: 23013765
[TBL] [Abstract][Full Text] [Related]
10. Radioprotective effect of amifostine on cells from cancer prone patients and healthy individuals studied by the G2 and PCC assays.
Manola KN; Terzoudi GI; Dardoufas CE; Malik SI; Pantelias GE
Int J Radiat Biol; 2003 Oct; 79(10):831-8. PubMed ID: 14630542
[TBL] [Abstract][Full Text] [Related]
11. Chromosomal radiosensitivity in breast cancer patients with a known or putative genetic predisposition.
Baeyens A; Thierens H; Claes K; Poppe B; Messiaen L; De Ridder L; Vral A
Br J Cancer; 2002 Dec; 87(12):1379-85. PubMed ID: 12454765
[TBL] [Abstract][Full Text] [Related]
12. Chromosomal aberrations and in vitro radiosensitivity: intra-individual versus inter-individual variability.
Vral A; Thierens H; Baeyens A; De Ridder L
Toxicol Lett; 2004 Apr; 149(1-3):345-52. PubMed ID: 15093280
[TBL] [Abstract][Full Text] [Related]
13. Potential for the G2/M arrest assay to predict patient susceptibility to severe reactions following radiotherapy.
Perez A; Grabenbauer GG; Sprung CN; Sauer R; Distel LV
Strahlenther Onkol; 2007 Feb; 183(2):99-106. PubMed ID: 17294115
[TBL] [Abstract][Full Text] [Related]
14. Chromosomal in-vitro radiosensitivity of lymphocytes in radiotherapy patients and AT-homozygotes.
Dunst J; Neubauer S; Becker A; Gebhart E
Strahlenther Onkol; 1998 Oct; 174(10):510-6. PubMed ID: 9810318
[TBL] [Abstract][Full Text] [Related]
15. The potential role of G2- but not of G0-radiosensitivity for predisposition of prostate cancer.
Borgmann K; Raabe A; Reuther S; Szymczak S; Schlomm T; Isbarn H; Gomolka M; Busjahn A; Bonin M; Ziegler A; Dikomey E
Radiother Oncol; 2010 Jul; 96(1):19-24. PubMed ID: 20452694
[TBL] [Abstract][Full Text] [Related]
16. Post-irradiation DNA synthesis inhibition and G2 phase delay in radiosensitive body cells from non-Hodgkin's lymphoma patients: an indication of cell cycle defects.
Hannan MA; Kunhi M; Einspenner M; Khan BA; al-Sedairy S
Mutat Res; 1994 Dec; 311(2):265-76. PubMed ID: 7526192
[TBL] [Abstract][Full Text] [Related]
17. The G2 chromosomal radiosensitivity assay.
Bryant PE; Gray L; Riches AC; Steel CM; Finnon P; Howe O; Kesterton I; Vral A; Curwen GB; Smart V; Tawn EJ; Whitehouse CA
Int J Radiat Biol; 2002 Sep; 78(9):863-6. PubMed ID: 12428927
[TBL] [Abstract][Full Text] [Related]
18. Increased chromosomal radiosensitivity in breast cancer patients: a comparison of two assays.
Scott D; Barber JB; Spreadborough AR; Burrill W; Roberts SA
Int J Radiat Biol; 1999 Jan; 75(1):1-10. PubMed ID: 9972785
[TBL] [Abstract][Full Text] [Related]
19. Chromosomal radiosensitivity, cancer predisposition and response to radiotherapy.
Scott D
Strahlenther Onkol; 2000 May; 176(5):229-34. PubMed ID: 10847120
[TBL] [Abstract][Full Text] [Related]
20. Relationship between in vitro chromosomal radiosensitivity of peripheral blood lymphocytes and the expression of normal tissue damage following radiotherapy for breast cancer.
Barber JB; Burrill W; Spreadborough AR; Levine E; Warren C; Kiltie AE; Roberts SA; Scott D
Radiother Oncol; 2000 May; 55(2):179-86. PubMed ID: 10799730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
